Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)
Sensus Healthcare (SRTS) posted quarterly Cash from Financing Activities of -$5000.0 for Q4 2025, down 117.86% year-over-year from $28000.0 in Q4 2024, and up 98.33% quarter-over-quarter from -$300000.0 in Q1 2025.
Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Sensus Healthcare's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$5000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0; the TTM figure through Dec 2025 stood at -$305000.0 (down 535.42% YoY), while the FY2025 annual figure was -$305000.0, down 2133.33% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$5000.0, up from -$300000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $273000.0 in Q1 2022, with the low at -$1.9 million in Q4 2022.
- The 5-year median for Cash from Financing Activities is -$39000.0 (2023), against an average of -$200400.0.
- Peak annual rise in Cash from Financing Activities reached 555.0% in 2022, while the deepest fall reached 3481.48% in 2022.
- Sensus Healthcare's Cash from Financing Activities stood at -$54000.0 in 2021, then plunged by 3481.48% to -$1.9 million in 2022, then jumped by 99.64% to -$7000.0 in 2023, then soared by 500.0% to $28000.0 in 2024, then sank by 117.86% to -$5000.0 in 2025.
- Business Quant data shows SRTS's Cash from Financing Activities at -$5000.0 in Q4 2025, -$300000.0 in Q1 2025, and $28000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Sensus Healthcare | 52.18 Mn | 37.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | -1.93 Mn |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | 211,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | -978,000.00 |
| Jun 30, 2022 | -978,000.00 |